Neisseria meningitidis tetravalent antibodies (Serogroups A, C, W-135 and Y), IgG
Neisseria meningitidis tetravalent antibodies (Serogroups A, C, W-135 and Y), IgG-994
Neisseria meningitidis tetravalent antibodies (Serogroups A, C, W-135 and Y), IgG
994
LAB994
MSO
Meningococcal IgG Vaccine Response
N. Meningitidis IgG Vaccine Response
Neisseria meningitidis
N. Meningitidis IgG Vaccine Response
Neisseria meningitidis
N.meningitidis Type A IgG
N.meningitidis Type C IgG
N.meningitidis Type Y IgG
N.meningitidis Type W-135 IgG
N.meningitidis Type C IgG
N.meningitidis Type Y IgG
N.meningitidis Type W-135 IgG
To assess immunocompetence following Neisseria meningitidis vaccination.
To assess suspected immunodeficiency, use pre- and postvaccination serology. Do not use for diagnosis of infection or serotyping.
Serum
1.0 mL
0.2 mL
Immediatley following collection, mix sample by gently inverting 5 times
- Allow sample to clot for a minimum of 30 minutes
- Spin within two (2) hours of sample collection
- Allow sample to clot
- Spin within two (2) hours of sample collection
- Transfer serum to a Transfer vial/tube with cap - 12mL (LabCorp), labelled as serum
Refrigerated (preferred)- 2 weeks
Frozen - 1 year
Ambient - 48 hours
ARUP Laboratories Inc (2001603) via LabCorp (247315): R-NX
Mo
8 days
Quantitative Multiplex Bead Assay
≤ 0.9 µg/mL Antibody concentration not protective
1.0 - 2.0 µg/mL Equivocal
≥ 2.1 µg/mL Antibody to Neisseria meningitidis detected. Suggestive of protection.
86741 x 4
Result; 247316 N.Meningitidis Type A IgG 28546-0;247317 N.Meningitidis Type C IgG 28547-8;247318 N.Meningitids Type Y IgG 60466-0; 247319 N.Meninigitidis Type W-135 IgG 60465-2
05/24/2019
12/18/2023
12/18/2023